Changes in the Use of Montelukast for Asthma After a US Food and Drug Administration Boxed Warning

By afschroeder • May 23, 2026

Shanmugam H, Kesselheim AS, Liu ITT, Feldman WB, Rome BN. Changes in the Use of Montelukast for Asthma After a US Food and Drug Administration Boxed Warning. JAMA Netw Open. 2026 May 1;9(5):e2614274. doi: 10.1001/jamanetworkopen.2026.14274. PMID: 42172028; PMCID: PMC13197876.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Multicytokine-based transcriptome-wide association study for 7 inflammatory skin disorders identifies candidate causal genes in keratinocytes

Zhang H, Patrick MT, Sarkar MK, Bogle R, Li Q, Uppala R, Perez White BE, Petukhova L, Dand N, Stuart PE, Christiano AM, Simpson MA,[...]

Mpox seroprevalence among sex workers and men who have sex with men preceding sustained urban outbreak in the Democratic Republic of the Congo

Mukadi PK, Merritt S, Nkuba-Ndaye A, Halbrook M, Anta Y, Bodisa Matamu T, Hasivirwe Vakaniaki E, Mukadi-Bamuleka D, Harrigan RJ, Lunyanga L, Kacita C, Kompany[...]

SARS-CoV-2 nucleocapsid induces hyperinflammation and vascular leakage through the Toll-like receptor signaling axis in macrophages

Yao Z, Alvarez PA, Chavez C, Delgado Y, Kaushal P, Buchholz DW, Austin D, Li Q, Yu Y, Zaiss AK, Arumugaswami V, Ding Q, Hsu[...]